Table 4.
WSS95 of the top 6 combinations.
| SR report topic | TI+AB | TI+AB +MH |
TI+AB +PT |
TI+AB +AU |
TI+AB +PT+AU |
TI+AB+MH +PT+AU |
| ACE inhibitors | 76.38 | 76.85 | 74.29 | 75.79 | 73.70 | 75.08 |
| ADHD | 80.38 | 79.79 | 67.92 | 80.14 | 67.92 | 56.17 |
| Antihistamines | 16.13 | 10.65 | 24.52 | 16.13 | 24.52 | 18.39 |
| Atypical antipsychotics | 20.89 | 14.20 | 17.95 | 20.63 | 17.77 | 14.38 |
| Beta blockers | 60.14 | 60.09 | 65.01 | 60.96 | 64.72 | 65.21 |
| Calcium channel blockers | 18.23 | 18.64 | 17.32 | 18.39 | 17.49 | 22.82 |
| Estrogens | 33.42 | 36.14 | 22.55 | 33.97 | 22.55 | 29.08 |
| NSAIDS | 72.26 | 75.57 | 77.35 | 70.48 | 76.34 | 77.86 |
| Opioids | 6.01 | 11.75 | 8.98 | 5.95 | 8.98 | 12.17 |
| Oral hypoglycemics | 11.33 | 13.12 | 13.52 | 11.13 | 13.52 | 12.72 |
| Proton pump inhibitors | 19.20 | 21.31 | 19.65 | 19.05 | 19.65 | 20.11 |
| Skeletal muscle relaxants | 41.94 | 46.44 | 58.55 | 41.87 | 58.49 | 60.01 |
| Statins | 29.10 | 27.11 | 27.80 | 30.96 | 27.71 | 26.07 |
| Triptans | 48.29 | 51.71 | 39.64 | 50.52 | 39.79 | 40.98 |
| Urinary incontinence | 12.84 | 11.01 | 20.80 | 12.84 | 20.80 | 14.37 |
| Average | 36.44 | 36.96 | 37.06 | 36.59 | 36.93 | 36.35 |